Serum concentrations of cytokines in patients with Hodgkin's disease
- 31 December 1994
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (3), 321-324
- https://doi.org/10.1016/0959-8049(94)90249-6
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Soluble CD8, CD25 and CD30 antigens as prognostic markers in patients with untreated Hodgkin's lymphomaAnnals of Oncology, 1992
- Activation of cytokines in Hodgkin's diseaseAnnals of Oncology, 1992
- in situ expression of the IL‐I‐α and tnf‐α genes by reed‐sternberg cells in Hodgkin's diseaseInternational Journal of Cancer, 1992
- Preliminary report: effects of interleukin-1 on platelet countsThe Lancet, 1990
- Involvement of cyclic adenosine monophosphate in the interleukin 4 inhibitory effect on interleukin 2-induced lymphokine-activated killer generation.Journal of Clinical Investigation, 1990
- Increase of TNF-α Serum Levels in Major Transplant-Related Complications of Human Bone Marrow Transplantation— Association with Acute Graft-Versus-Host Disease and Activation of Host MacrophagesPublished by Springer Nature ,1990
- Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.Journal of Clinical Investigation, 1989
- Tumor Necrosis Factor and Disease Severity in Children with Falciparum MalariaNew England Journal of Medicine, 1989
- SERUM LEVELS OF INTERLEUKIN-6 AND ACUTE PHASE RESPONSESThe Lancet, 1987
- Anti-interleukin-1 reactive cells in Hodgkin's diseaseCancer, 1987